SCHEMBL9034902

SCHEMBL9034902

CCCCCn1c(C(F)(F)F)c(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.42
AGTR2 P50052 10/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9036889 0.98 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9036337 0.94 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9035651 0.93 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9034970 0.93 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9037061 0.93 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9035801 0.93 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9036723 0.91 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9554323 0.91 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL9036779 0.91 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9035389 0.90 AGTR1 (0.37) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP claimed
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP disclosed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed